Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study.
Januschowski K, Dimopoulos S, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G; Bevacizumab Study Group Venous Occlusion; Meyer CH, Szurman GB. Januschowski K, et al. Among authors: spitzer b. Acta Ophthalmol. 2015 Aug;93(5):e400-e402. doi: 10.1111/aos.12600. Epub 2015 Jan 25. Acta Ophthalmol. 2015. PMID: 25619682 Free article. No abstract available.
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion.
Jaissle GB, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Heimann H, Meyer CH; Retinal Vein Occlusion Study Group. Jaissle GB, et al. Among authors: spitzer b. Graefes Arch Clin Exp Ophthalmol. 2011 Feb;249(2):183-92. doi: 10.1007/s00417-010-1470-2. Epub 2010 Aug 18. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21337042 Free PMC article.
Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicentre study.
Szurman GB, Januschowski K, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Dimopoulos S; Bevacizumab Study Group Venous Occlusion; Meyer CH. Szurman GB, et al. Among authors: spitzer b. Acta Ophthalmol. 2017 May;95(3):e245-e246. doi: 10.1111/aos.12976. Epub 2016 Feb 1. Acta Ophthalmol. 2017. PMID: 26833721 Free article. No abstract available.
Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion.
Januschowski K, Feltgen N, Pielen A, Spitzer B, Rehak M, Spital G, Dimopoulos S; Bevacizumab Study Group Venous Occlusion; Meyer CH, Szurman GB. Januschowski K, et al. Among authors: spitzer b. Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):457-462. doi: 10.1007/s00417-016-3471-2. Epub 2016 Sep 8. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 27632214
Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion.
Szurman GB, Meyer CH, Feltgen N, Pielen A, Spitzer B, Rehak M, Spital G, Dimopoulos S, Szurman P; Bevacizumab Study Group Venous Occlusion; Januschowski K. Szurman GB, et al. Among authors: spitzer b. Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):1045-1046. doi: 10.1007/s00417-017-3618-9. Epub 2017 Feb 21. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28224287 No abstract available.
Comparative antiproliferative and cytotoxic profile of bevacizumab (Avastin), pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells.
Spitzer MS, Yoeruek E, Sierra A, Wallenfels-Thilo B, Schraermeyer U, Spitzer B, Bartz-Schmidt KU, Szurman P. Spitzer MS, et al. Among authors: spitzer b. Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1837-42. doi: 10.1007/s00417-007-0568-7. Epub 2007 Mar 9. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17347807
Cyclo-oxygenase-2 expression in photon-radiated and non-radiated uveal melanomas.
Suesskind D, Paulsen F, Buchgeister M, Spitzer B, Rohrbach JM, Bartz-Schmidt KU, Spitzer MS. Suesskind D, et al. Among authors: spitzer ms, spitzer b. Acta Ophthalmol. 2010 Aug;88(5):582-7. doi: 10.1111/j.1755-3768.2008.01475.x. Epub 2009 Apr 23. Acta Ophthalmol. 2010. PMID: 19432844 Free article.
Circulating melanoma cells in peripheral blood of patients with uveal melanoma before and after different therapies and association with prognostic parameters: a pilot study.
Suesskind D, Ulmer A, Schiebel U, Fierlbeck G, Spitzer B, Spitzer MS, Bartz-Schmidt KU, Grisanti S. Suesskind D, et al. Among authors: spitzer ms, spitzer b. Acta Ophthalmol. 2011 Feb;89(1):17-24. doi: 10.1111/j.1755-3768.2009.01617.x. Acta Ophthalmol. 2011. PMID: 21272286 Free article.
123 results